BCD Bioscience is a biotechnology company that creates precision prebiotics from natural fiber sources, including food waste. The company has a validated prediction and rapid screening platform for assessing prebiotic functional properties, microbial impacts, and postbiotic production. Its technology can produce precision oligosaccharides from most natural fiber sources and delivers deep insights into carbohydrate structure and bacterial utilization. Commercial applications cited include functional foods, medical nutrition, and therapeutics. Future plans described in the article include obtaining regulatory approvals for lead products, upscaling production, and expanding the product pipeline. BCD was founded in 2019 as a UC Davis spin-out and is based in Davis, Calif.

Total raised

$12M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2022